3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl) -acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors

Details for Australian Patent Application No. 2005309776 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Charrier, Jean-Damien; Mortimore, Michael; Studley, John R.; Knegtel, Ronald

Agent Cullens

Pub. Number AU-B-2005309776

PCT Pub. Number WO2006/057961

Priority 60/630,926 24.11.04 US

Filing date 21 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 22 December 2011

International Classifications

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/4436 (2006.01)

A61K 31/4439 (2006.01)

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057961 Priority application(s): WO2006/057961

22 December 2011 Application Accepted

  Published as AU-B-2005309776

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309779-Bi-directional tamper resistant temperature dial

2005309775-Space heater with pretreated heat exchanger